Traders say ARGENX's stock price is expected to drop 10% due to the termination of late-stage research into the autoimmune disease of Sjogren's syndrome.

Traders say ARGENX's stock price is expected to drop 10% due to the termination of late-stage research into the autoimmune disease of Sjogren's syndrome.